Clarification sought fromAurobindo Pharma Ltd

| Updated on March 05, 2018 Published on March 05, 2018

The Exchange has sought clarification from Aurobindo Pharma Ltd on March 05, 2018 with reference to news flashed on www.moneycontrol.com dated March 05, 2018 quoting "US FDA observations - Aurobindo Unit 4 inspected by US FDA from February 12-20 and issues 9 observations."

The reply is awaited.

Source : BSE - www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on March 05, 2018
This article is closed for comments.
Please Email the Editor